Dr. Piotr Tomasz Tekiela, MD

Dr. Tekiela practices at Piedmont Mountainside Hospital in Jasper, Georgia, part of Piedmont Healthcare.

Dr. Tekiela's NPI, 1902268626, was assigned on March 22, 2016. Dr. Tekiela graduated from Jagiellonian University Medical College in 2016. Dr. Tekiela holds Florida license ME165404.

Dr. Tekiela's primary practice is Piedmont Mountainside Hospital, at 1266 Highway 515 South, Jasper, GA 30143 in Pickens County. The practice phone is (706) 692-2441.

Dr. Tekiela's primary practice is Piedmont Mountainside Hospital in Jasper, Georgia, part of Piedmont Healthcare. Dr. Tekiela is also affiliated with AdventHealth Orlando. The medical group on file is Baptist Health Medical Group. Dmand AI also links Dr. Tekiela to 8 more hospitals, 33 medical groups and 18 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tekiela practices, 28 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tekiela's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Tekiela is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Tekiela's licenses on file in 15 states: Florida, Colorado, Delaware, Idaho, New Jersey, Nevada, South Carolina, Arizona, California, Michigan, Montana, Pennsylvania, Texas, Utah and Washington.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, head injury, lower back pain and mobility impairment among the conditions Dr. Tekiela treats.

CMS data shows 134 Medicare services from Dr. Tekiela across 3 procedure codes in 2024, for 166 Medicare patients. Medicare paid $17,291 for them.

CMS counts 166 Medicare patients who saw Dr. Tekiela in 2024. The largest group is 75 to 84, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tekiela's median patient age at 67, with 59% women.

In 2024, Dr. Tekiela wrote 115 Medicare Part D claims for 39 patients. 74% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $5,728 in total drug cost. In 2023, CMS named 452 claims across 22 drugs.

Dr. Tekiela accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tekiela as offering telehealth.

Dmand AI links 3 papers to Dr. Tekiela, published from 2021 to 2023. Dr. Tekiela's most frequent co-authors are Jennifer Majersik, MD, Holly Kristine Ledyard, MD and Peter P. Taillac, MD.

CMS Open Payments shows 4 general payments to Dr. Tekiela from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. W. L. Gore & Associates, Inc. paid the most, $276.

Dr. Tekiela graduated from Jagiellonian University Medical College in 2016.

Dr. Tekiela is in network with 23 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.